KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Notes Payables (2021 - 2025)

Fulgent Genetics' Notes Payables history spans 5 years, with the latest figure at $476000.0 for Q4 2025.

  • For Q4 2025, Notes Payables rose 15.53% year-over-year to $476000.0; the TTM value through Dec 2025 reached $476000.0, up 15.53%, while the annual FY2025 figure was $476000.0, 15.53% up from the prior year.
  • Notes Payables for Q4 2025 was $476000.0 at Fulgent Genetics, roughly flat from $476000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $6.1 million in Q1 2022 and bottomed at $412000.0 in Q2 2024.
  • The 5-year median for Notes Payables is $1.2 million (2023), against an average of $2.7 million.
  • The largest annual shift saw Notes Payables crashed 92.64% in 2024 before it increased 15.53% in 2025.
  • A 5-year view of Notes Payables shows it stood at $5.9 million in 2021, then decreased by 4.42% to $5.6 million in 2022, then plummeted by 79.02% to $1.2 million in 2023, then crashed by 65.17% to $412000.0 in 2024, then increased by 15.53% to $476000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Notes Payables are $476000.0 (Q4 2025), $476000.0 (Q3 2025), and $476000.0 (Q2 2025).